Study design (if review, criteria of inclusion for studies)
Project of Health technology assessment
Participants
General population. Adults of reproductive age
Interventions
Genetic testing for cystic fibrosis for CF carrier screening
Outcome measures
The impacts of offering a cystic fibrosis (CF) carrier screening to the general population
Main results
i) a lack of robust and updated data; ii) a return on investment up to six years from the screening's introduction, despite important economic and organizational efforts; iii) a general positive attitude of healthcare professionals, people with CF, families and general population; iv) possible issues related to the social impact.